From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Lipid Management>
  4. Archives

Lipid Management: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 101-125 of 202 are shown

ILLUMINATE: Many Dark Areas Remain

Despite raising HDL levels, torcetrapib significantly increased patients’ risks for cardiovascular events.

Apolipoprotein E Genotypes and Cardiovascular Risks

In this meta-analysis, researchers found roughly linear relationships between apo E genotypes and both LDL cholesterol levels and coronary disease.

Long-Term Follow-Up of a Landmark Statin Trial

The benefits of statin therapy lasted 10 years.

The West of Scotland Coronary Prevention Study: Long-Term Results

The benefits of statins for primary prevention of coronary heart disease stand the test of time.

HDL Levels and Cardiovascular Risk in Patients with Very Low LDL Levels

HDL level was inversely correlated with cardiovascular events, regardless of LDL level.

Does HDL Matter When Statins Are Working?

In a post hoc analysis of TNT trial data, HDL levels predicted cardiovascular events in patients with very low LDL levels.

Molecule Links Dyslipidemia, Oxidative Stress, and Thrombosis

A newly identified component of oxidized LDL appears to increase platelet reactivity.

Statins Neither Protect Against Nor Promote Colorectal Cancer

Data from a large general practice database suggest that 4 years of statin therapy has no effect on cancer risk.

Nonfasting Triglycerides as an Indicator of Cardiovascular Risk

Nonfasting, but not fasting, triglyceride levels were associated with CV event rate independently of other risk factors.

Revised Guidelines for Unstable Angina and Non-ST-Segment-Elevation MI

The 2007 guidelines emphasize early diagnosis and risk stratification to guide decisions on invasive vs. noninvasive treatment.

Statin–Clopidogrel Interactions: Are They Clinically Important?

Statins didn’t appear to affect the efficacy of clopidogrel in a secondary analysis of previously published data.

What’s the Utility of the Apo B:Apo A-1 Ratio?

In a large, prospective study, apolipoproteins had no advantage over other lipid measures in assessing risk for CHD.

Are Nonfasting Better Than Fasting Triglyceride Levels at Predicting Cardiac Events?

In two large cohort studies, CVD risk correlated more strongly with nonfasting than with fasting levels, but the clinical significance of hypertriglyceridemia is still unclear.

Lipids and Stroke Risk in Women

Increased cholesterol levels were associated with increased ischemic stroke rates in a large cohort from the Women’s Health Study.

High-Dose Atorvastatin in Patients 65 Years or Older

The relative benefits of a high versus a low dose were found in older as well as in younger patients.

High-Dose Lipid-Lowering for Older Adults with CHD

Higher statin doses achieve additional benefits.

Traditional Mediterranean Diet Lowers Oxidized LDL

Early findings from the PREDIMED trial show a beneficial effect on some cardiovascular risk factors.

What Caused the Decline in Cardiac Death Rate from 1980 to 2000?

A new analysis credits improved treatment and reduction in risk factors about equally.

Does Aerobic Exercise Increase HDL Levels?

Results of a meta-analysis show small improvements and a need for more data.

Soy Nuts and Blood Pressure

Findings from a small trial suggest a big benefit.

Effect of Soy Intake on Blood Pressure and Lipids

In hypertensive women who added soy to their diets, blood pressure decreased.

Effect of Exercise on HDL

A meta-analysis finds that duration of aerobic exercise, but not frequency or intensity, is associated with change in HDL levels.

Coenzyme Q10 for Relief of Muscle Ache in Patients Treated with Statins

In a small study, supplements conferred a considerable benefit.

Apolipoprotein Ratio Does Not Improve Prediction of Cardiac Risk

The ratio of apolipoprotein B to apolipoprotein A-I was associated with coronary artery disease but added little to existing measures of risk assessment.

The Apo B:Apo A-I Ratio: A Role in CV Risk Assessment?

This ratio performed no better than the total cholesterol:HDL cholesterol ratio in determining CAD risk.

Items 101-125 of 202 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.